These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35763354)

  • 41. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
    Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
    Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
    Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel SPEG mutations in congenital myopathies: Genotype-phenotype correlations.
    Qualls AE; Donkervoort S; Herkert JC; D'gama AM; Bharucha-Goebel D; Collins J; Chao KR; Foley AR; Schoots MH; Jongbloed JDH; Bönnemann CG; Agrawal PB
    Muscle Nerve; 2019 Mar; 59(3):357-362. PubMed ID: 30412272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
    Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The dynamin-2-gene related centronuclear myopathy].
    Bitoun M
    Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
    Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
    Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
    Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myotonia in DNM2-related centronuclear myopathy.
    Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
    J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Centronuclear myopathies: a widening concept.
    Romero NB
    Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The intragenic microRNA
    Chen X; Gao YQ; Zheng YY; Wang W; Wang P; Liang J; Zhao W; Tao T; Sun J; Wei L; Li Y; Zhou Y; Gan Z; Zhang X; Chen HQ; Zhu MS
    J Biol Chem; 2020 Jun; 295(26):8656-8667. PubMed ID: 32354746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.
    Jungbluth H; Cullup T; Lillis S; Zhou H; Abbs S; Sewry C; Muntoni F
    Neuromuscul Disord; 2010 Jan; 20(1):49-52. PubMed ID: 19932620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease.
    Luo S; Rosen SM; Li Q; Agrawal PB
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
    Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
    J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy.
    Gómez-Oca R; Edelweiss E; Djeddi S; Gerbier M; Massana-Muñoz X; Oulad-Abdelghani M; Crucifix C; Spiegelhalter C; Messaddeq N; Poussin-Courmontagne P; Koebel P; Cowling BS; Laporte J
    Nat Commun; 2022 Nov; 13(1):6849. PubMed ID: 36369230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
    Gómez-Oca R; Cowling BS; Laporte J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review.
    Zhang G; Xu M; Huang T; Lin W; Chen J; Chen W; Chang X
    BMC Pediatr; 2021 Apr; 21(1):209. PubMed ID: 33926407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.